Deschloroetizolam
1Provenance card
the boundary, as counts
Sources
2116 with DOI
1 strong · 16 moderate · 4 weak
Compilations
12026-05-09T16:32:05.224Z
pipeline-v5 · prompt hash not recorded — run predates 2026-09
Decisions
37last ruled 2026-06-04
1 awaiting a ruling
Issued documents
42026-10-19T20:31:21.127Z
notice · info card · emergency
Searches
152 with no results
queries and counts on the build
Claims checked
6634 supported
34 supported · 32 not
Correspondence
0received
consent field ships in Phase 4
Edges
217
derivations recorded for this entity
Complete over 21 sources, 1 compilation, and 37 decisions.Not here: the private journal (never); 1 proposal awaiting a ruling (listed as pending only).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/deschloroetizolam/archive
Timeline
what happened, newest first — claims, searches and artifacts stay inside Build
- 2026-10-19issueIssued info_card
- 2026-10-02srcDesigner Benzodiazepines: A Review of Published Data and Public Health Significance
- 2026-10-02srcThe emergence of new psychoactive substance (NPS) benzodiazepines: A review.
- 2026-10-02srcNotable Drug-Drug Interaction Between Etizolam and Itraconazole in Poor Metabolizers of Cytochrome P450 2C19
- 2026-10-02srcDesigner Benzodiazepines: Another Class of New Psychoactive Substances.
- 2026-10-02srcCharacterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites
- 2026-10-02srcUrine analysis of 28 designer benzodiazepines by liquid chromatography-high-resolution mass spectrometry
- 2026-10-02srcOccurrence and time course of NPS benzodiazepines in Sweden - results from intoxication cases in the STRIDA project.
- 2026-10-02srcDocumentation of a Little-Studied Designer Benzodiazepine After a Controlled Single Administration: II. Concentration Profile of Deschloroetizolam in Saliva
- 2026-10-02srcDesigner benzodiazepines' pharmacological effects and potencies: How to find the information
- 2026-10-02srcGABA(A) receptor alpha subunits differentially contribute to diazepam tolerance after chronic treatment
- 2026-10-02src'New/Designer Benzodiazepines': An Analysis of the Literature and Psychonauts' Trip Reports
- 2026-10-02srcRecent findings and advancements in the detection of designer benzodiazepines: a brief review
- 2026-10-02srcFlubromazolam – A new life-threatening designer benzodiazepine
- 2026-10-02srcBenzodiazepine Dependence: Clinical and Molecular Aspects, Preventive Strategies and Therapeutic Approaches.
- 2026-10-02srcNovel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects
- 2026-10-02srcDesigner Benzodiazepines: A Review of Toxicology and Public Health Risks
- 2026-10-02srcPharmacological actions of Y-24180: II. Interactions with PAF and benzodiazepine receptors
- 2026-10-02srcThe GABAA-BZR complex as target for the development of anxiolytic drugs
- 2026-10-02srcDeschloroetizolam
- 2026-10-02srcDeschloroetizolam - HandWiki
- 2026-10-02srcFederal Register: Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act
- 2026-09-04issueIssued emergency
- 2026-09-04issueIssued info_card
- 2026-09-04issueIssued notice
- 2026-07-03proposaldependence · taper
- 2026-06-04proposal34 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
- 2026-06-04publicationPublication — backfill
- 2026-05-09revisionRevision 1
- 2026-05-09absenceSearched ClinicalTrials.gov for "deschloroetizolam" — no results
- 2026-05-09absenceSearched ClinicalTrials.gov for "deschloroetizolam" — no results
- 2026-05-09genGeneration — pipeline-v5 · with 3 morepipeline-v5
- 2026-05-09rungeneration run
The same entries, as forms: six forms.